
Newbury Pharmaceuticals Investor Relations Material
Latest events

Q3 2025
9 Jul, 2025

Q2 2025
9 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Newbury Pharmaceuticals
Access all reports
Newbury Pharmaceuticals AB is a Sweden-based company specializing in specialty prescription drugs. The company's portfolio includes products across therapeutic areas such as oncology, rare diseases, and neurology. Newbury Pharmaceuticals primarily serves the Scandinavian market, focusing on developing both proprietary and licensed pharmaceutical products. The company is headquartered in Lund, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
NEWBRY
Country
🇸🇪 Sweden